Monday, July 28, 2025
HomeTagsHealthcare

Healthcare

Transgene and BioInvent Announce Positive Progress for BT-001

Transgene, a biotech company that designs and develops virus-based immunotherapeutics against cancer, and BioInvent International AB (“BioInvent”), a biotech company focused on the discovery...

Novel Pre-clinical Results Regarding Oncosec’s Intratumoral Electroporation Platform

OncoSec Medical Incorporated, a clinical-stage biotechnology company focused on developing intratumoral immunotherapies to stimulate the patient's own immune system to target and eradicate cancer,...

BioFluidica Next-Generation Liquid Biopsy Platform Uncovers Undiagnosed HER2+ Patients

Biofluidica announced the results of a breast cancer study comparing invasive needle biopsies with their non-invasive, highly sensitive Next-Generation Liquid Biopsy platform, LiquidScan™ to...

Antios Therapeutics’ ATI-2173 Demonstrates Suppression of Hepatitis B Virus in Phase 2a Study

Antios Therapeutics, Inc. (Antios), a clinical-stage biopharmaceutical company developing transformative treatments for hepatitis B virus (HBV), announced new data from the Phase 2a clinical...

Astellas Announces FDA Update on the FORTIS Clinical Trial of AT845 in Adults

Astellas Pharma Inc. announced that the US Food and Drug Administration (FDA) has placed a clinical hold on the FORTIS Phase 1/2 trial following...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics